IRVINE, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Phoenix Energy One, LLC (NYSE American, PHXE.P) (“Phoenix Energy” or the “Company”), an energy company focused on oil and gas exploration and production across key U.S. basins, with a primary footprint in the Williston Basin in North Dakota and Montana, filed its Quarterly Report for the three months ended March 31, 2026 on May 13, 2026, thereby announcing its financial and operating results for the first quarter of 2026. Q1 2026 HighlightsGenerated revenue of $298.7 million in Q1 2026 as compared to $115.7 million in Q1 2025, net loss of $140.1 million as compared to net income of $5.6 million in Q1 2025, EBITDA of $(27.6) million as compared to $72.0 million in Q1 2025, and Adjusted EBITDA of $130.2 million as compared to $69.2 million in Q1 2025; Amended the Company’s term...

ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion. Inflammasome ASC Inhibitor IC 100 is the next evolution of inflammasome inhibitors designed for unparalleled control of disease-causing inflammation by (1) inhibiting multiple inflammasomes activated in numerous diseases, not just NLRP3, and (2) attenuating spread and perpetuation of inflammation by uniquely inhibiting ASC specks.Lead indication: Cardiometabolic conditions associated with obesity Value driving milestones: file IND Q4-2026; Phase 1 SAD read-out H1-2027Cholesterol Efflux Mediator VAR 200 is expected to be a disease-modifying renal drug by targeting unaddressed renal lipotoxicity to attenuate renal damage and slow disease progression.Lead indication: orphan disease FSGS (focal...

Date: Wednesday, May 20, 2026Time: 3:00 pm (Eastern Time) NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — You are invited to participate in TerraForm Power Operating, LLC’s First Quarter 2026 Results Webcast and Conference Call on May 20, 2026 at 3:00 p.m. (Eastern Time) to discuss results and current business initiatives with senior management. These results will be made available on our website at www.terraform.com in the form of unaudited consolidated financial statements for the periods ended March 31, 2026 and 2025 under “Financials” prior to the webcast and conference call. Participants can join by conference call or webcast: Conference Call Please pre-register by conference call clicking here Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN. This process will bypass the operator and avoid...

Q1 2026 Revenue of $21.1 million Q1 2026 Net loss of $8.1 million Q1 2026 Adjusted EBITDA loss of $2.3 millionAll figures are reported in United States dollars ($) unless otherwise indicated LAS VEGAS, May 13, 2026 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced its financial results for the three-month period ended March 31, 2026. Planet 13’s financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). “Q1 was a transition quarter that reflected the cost of the strategic work we executed over the past several quarters including the California exit, the Wagon Trail consolidation in Nevada, and the disciplined cost reduction across the organisation....

– Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046 – – FDA feedback on use of new form of brilaroxazine in the RECOVER-2 trial and future NDA expected in mid-2026 –– Initiation of patient enrollment in RECOVER-2 registrational Phase 3 trial expected Q3 2026 – CUPERTINO, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today reported financial results for the first quarter ended March 31, 2026 and summarized recent business highlights. “During...

HOUSTON, May 13, 2026 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the first quarter of 2026. Key HighlightsThe Company ended the quarter with positive equity of $157.1 million. This provides further basis for the Company to attain compliance with NYSE listing requirements Reduced net debt (gross debt less cash and reinvestment proceeds) to $108.3 million vs $180.2 million in Q4 2025 Divested West Quito Assets for net proceeds of $60.1 million, utilizing $45.6 million to repay amounts outstanding under our Term Loan Executed a private placement to an institutional investor for purchase of common stock at $5.50 per share for total gross proceeds of $15.0 million Converted 7,803 shares of preferred stock to 1.8 million common...

PHOENIX, May 13, 2026 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, reported results for the first quarter ended March 31, 2026. Unless otherwise noted, all comparisons are to the corresponding period in the prior year. The company will hold a conference call at 1:00 p.m. Eastern time tomorrow to discuss the results (see dial-in information below). Q1 2026 Financial HighlightsTotal revenue increased 6.7% year-over-year (“YoY”) to $13.3 million. The increase was primarily due to the acquisition of seven water systems from Tucson Water in July 2025, organic connection growth, increased consumption and higher rates. Net loss totaled $0.4 million or ($0.01) per share, a decrease of $1.0 million YoY compared to net income of $0.6 million or $0.02 per share in the first...

MONTREAL, May 13, 2026 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or “the Corporation”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported its financial results today for the three-month and nine-month periods ended March 31, 2026. All amounts in this press release are in Canadian dollars, unless stated otherwise. Key Financial Highlights Q3-2026Total revenues of $32,347,377 compared to $30,446,165 last year, representing a 6% increase; Adjusted gross margin(1) on revenues from customers of 22.9% compared to 22.4% last year; Loss of $2,646,921 compared to a loss of $1,747,714 last year; Adjusted EBITDA(2) of $1,179,521 compared to $1,420,555 last year; Adjusted EBITDA(2) of $1,237,132 compared to $1,318,149 last year for the Advanced Materials, Plastics and Composite Products segment; Adjusted EBITDA(2)...

Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET LITTLETON, Mass., May 13, 2026 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its third quarter fiscal year 2026 for the period ended March 31, 2026. Q3 2026 Financial Highlights (3 Months Ended March 31, 2026):Revenue was $8.7 million, a quarterly record, compared to $4.2 million in the same quarter of the previous fiscal year, representing growth of approximately 108%, and compared to $7.4 million in the most recent sequential quarter. Production revenue, or total revenue net of engineering revenue, was $7.6 million, a quarterly record, compared to $3.3 million in the same...